The Current Ratio as of September 2024 (TTM) for Artelo Biosciences, Inc. (ARTL) is 14.58

According to Artelo Biosciences, Inc.’s latest financial reports and current stock price. The company's current Current Ratio is 14.58. This represents a change of -24.28% compared to the average of 19.25 of the last 4 quarters.

Artelo Biosciences, Inc. (ARTL) Historical Current Ratio (quarterly & annually)

How has ARTL Current Ratio performed in the past?

The mean historical Current Ratio of Artelo Biosciences, Inc. over the last ten years is 8.58. The current 14.58 Current Ratio has changed 16.89% with respect to the historical average. Over the past ten years (40 quarters), ARTL's Current Ratio was at its highest in in the September 2022 quarter at 42.30. The Current Ratio was at its lowest in in the November 2013 quarter at 0.

Artelo Biosciences, Inc. (ARTL) Current Ratio by Quarter and Year

Discovering the peaks and valleys of Artelo Biosciences, Inc. Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Artelo Biosciences, Inc. (ARTL) Average Current Ratio

How has ARTL Current Ratio performed in the past?

The current Current Ratio of Artelo Biosciences, Inc. (ARTL) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

Artelo Biosciences, Inc. (ARTL) Current Ratio vs. Peers

How is ARTL’s Current Ratio compared to its peers?

Artelo Biosciences, Inc.’s Current Ratio is greater than Aileron Therapeutics, Inc. (4.69), greater than Histogen Inc. (4.05), greater than Curis, Inc. (1.78), greater than Timber Pharmaceuticals, Inc. (0.50), greater than Salarius Pharmaceuticals, Inc. (2.98), greater than Vaccinex, Inc. (0.42), greater than Fresh Tracks Therapeutics, Inc. (6.98), less than Basilea Pharmaceutica AG (0), greater than Ascletis Pharma Inc. (4.10), less than AVAX Technologies, Inc. (16.58), greater than Brii Biosciences Limited (1.61), less than Pasithea Therapeutics Corp. (22.11), greater than Nutriband Inc. (6.20), greater than ZIVO Bioscience, Inc. (6.57), greater than MediciNova, Inc. (0.17), less than Eliem Therapeutics, Inc. (18.24), less than Akari Therapeutics, Plc (60.41), greater than Axcella Health Inc. (0.58), greater than Magenta Therapeutics, Inc. (0.80), less than null (14.64),

Build a custom stock screener for Artelo Biosciences, Inc. (ARTL) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Artelo Biosciences, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Artelo Biosciences, Inc. (ARTL) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Artelo Biosciences, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.